BN Business News
Add your company to Business Communicator →

Energy & environment · 17/05/2007Updated: 10/17/2026 · 1 min read

GlaxoSmithKline Announces Availability of Environmental Assessment for Unrestricted Release of Building 7 at Hamilton Facility

Summary

GlaxoSmithKline has made available an environmental assessment and finding of no significant impact for a license amendment allowing unrestricted release of Building 7 at its Hamilton, Montana facility, previously licensed under Byproduct Materials License No. 25-19852-01.

Original source language: Federal Register — Nuclear Regulatory CommissionOpen original release →

Explore insights

Business insights →